XML 97 R61.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions, Divestitures and Other Arrangements - Summary of Amounts Recognized for Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Aug. 27, 2021
Dec. 31, 2020
Aug. 01, 2020
Business Acquisition [Line Items]          
Goodwill $ 5,993 $ 6,172   $ 6,225  
KindredBio          
Business Acquisition [Line Items]          
Cash and cash equivalents     $ 31    
Other net working capital     13    
Property and equipment     33    
Deferred income taxes, net     (30)    
Total identifiable net assets     380    
Goodwill     35    
Settlement of liability related to previous license agreement     29    
Total consideration transferred     444    
KindredBio | Acquired in-process research and development          
Business Acquisition [Line Items]          
Intangible assets, primarily acquired in-process research and development (IPR&D)     $ 333    
Bayer Animal Business          
Business Acquisition [Line Items]          
Cash and cash equivalents         $ 169
Property and equipment         315
Intangible assets, primarily acquired in-process research and development (IPR&D)         65
Accounts receivable         10
Inventories         487
Prepaid expenses and other current assets         60
Marketed products         3,740
Assets held for sale         138
Accounts payable and accrued liabilities         (237)
Accrued retirement benefits         (220)
Other noncurrent assets and liabilities - net         (878)
Total identifiable net assets         3,649
Goodwill         3,129
Total consideration transferred         6,778
Bayer Animal Business | Marketed products          
Business Acquisition [Line Items]          
Marketed products         3,740
Bayer Animal Business | Acquired in-process research and development          
Business Acquisition [Line Items]          
Intangible assets, primarily acquired in-process research and development (IPR&D)         $ 65